Soligenix’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more

Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating

68/100

Founded:

1987

Status:

PublicOTCBBSNGX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Celtaxsys is Soligenix's top competitor. Celtaxsys is headquartered in Atlanta, Georgia, and was founded in 2005. Like Soligenix, Celtaxsys also operates in the Pharmaceuticals field. Celtaxsys generates 337% the revenue of Soligenix.

Alder BioPharmaceuticals is seen as one of Soligenix's top competitors. Alder BioPharmaceuticals's headquarters is in Bothell, Washington, and was founded in 2004. Like Soligenix, Alder BioPharmaceuticals also works within the Pharmaceuticals industry. Alder BioPharmaceuticals generates 192% of Soligenix's revenue.

VBI Vaccines has been one of Soligenix's top competitors. VBI Vaccines was founded in 2001, and its headquarters is in Cambridge, Massachusetts. VBI Vaccines is in the Biotechnology field. VBI Vaccines has 109 more employees than Soligenix.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Artizan Biosciences a competitor of Soligenix?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3.4M

Soligenix's revenue is the ranked 25th among it's top 10 competitors. The top 10 competitors average 3.8B. Over the last three quarters, Soligenix's revenue has decreased by 26.3%. Specifically, in Q2 2020's revenue was $ < 1M; in Q1 2020, it was $ < 1M; in Q4 2019, it was $ < 1M.

Acquisitions

No recent acquisitions found related to Soligenix

Soligenix Funding History

$7.1M$7.6M$16.2M$16.5M

Since Soligenix was founded in 1987, it has participated in 6 rounds of funding. In total Soligenix has raised $16.5M. Soligenix's last funding round was on Apr 2020 for a total of $350.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$350K - $1M

U.S. Small Business Administration.

Equity
Nov 2017
$2M
-
Private Placement
Oct 2017
$5.1M
-
Grant
Sep 2017
$1.5M
Equity
Dec 2015
$490K
-

Total Funding: $16.5M

Since Soligenix was founded in 1987, it has participated in 6 rounds of funding. In total Soligenix has raised $16.5M. Soligenix's last funding round was on Apr 2020 for a total of $350.0K

Investments

No recent investments found related to Soligenix

Soligenix News

September 15, 2020MarketScreener

Soligenix Announces Publication Demonstrating Thermostabilization of Filovirus Vaccine Antigens

(marketscreener.com) PRINCETON, N.J., Sept. 15, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage b... See more »
September 10, 2020MarketScreener

Advantages of the CiVax Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine

(marketscreener.com) PRINCETON, N.J., Sept. 10, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage b... See more »
September 9, 2020MarketScreener

Soligenix Invited to Present at Upcoming Virtual Investor Conferences

(marketscreener.com) PRINCETON, N.J., Sept. 9, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage bi... See more »
August 27, 2020MarketScreener

Soligenix to Present at the LD Micro Conference

(marketscreener.com) PRINCETON, N.J., Aug. 27, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage bi... See more »
July 28, 2020MarketScreener

Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

(marketscreener.com) PRINCETON, N.J., July 28, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage bi... See more »

Soligenix Press Releases

August 20, 2019AB Newswire

SNGX)

April 4, 2019PR Newswire

Soligenix Receives US Patent for Dusquetide Related Analogs

PRINCETON, N.J., April 4, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compa... See more »
April 4, 2019streetinsider

Soligenix Receives US Patent for Dusquetide Related Analogs

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company foc... See more »
April 4, 2019CentralCharts

Soligenix Receives US Patent for Dusquetide Related Analogs

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company foc... See more »
December 11, 2018PR Newswire

Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

PRINCETON, N.J., Dec. 11, 2018 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compa... See more »
December 11, 2018centralcharts

Soligenix to Receive $611,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

This competitive program enables approved technology and biotechnology businesses to sell their unuse... See more »
November 9, 2018PR Newswire

Soligenix Announces Recent Accomplishments And Third Quarter 2018 Financial Results

PRINCETON, N.J., Nov. 9, 2018 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compan... See more »

Soligenix Videos

Social Statistics

Headquarters

29 Emmons Dr Suite C-10

Princeton, New Jersey08540

1-609-538-8200

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Soligenix was founded in 1987. Soligenix's headquarters is located in Princeton, New Jersey, USA 08540. It has r...

CEO

Soligenix's President & CEO, Christopher J. Schaber, currently has an approval rating of 68%. Soligenix's primary competitors are Celtaxsys, Alder BioPharmaceuticals & VBI Vaccines.

Website

soligenix.com

Frequently Asked Questions about Soligenix

  1. When was Soligenix founded?

    Soligenix was founded in 1987
  2. Who is Soligenix's CEO?

    Soligenix's CEO is Christopher J. Schaber
  3. How much revenue does Soligenix generate?

    Soligenix generates $3.4M in revenue
  4. How much funding does Soligenix have?

    Soligenix has historically raised $16.5M in funding
  1. Where is Soligenix's headquarters?

    Soligenix's headquarters is in Princeton New Jersey, USA
  2. How many employees does Soligenix have?

    Soligenix has 14 employees
  3. What sector does Soligenix operate in?

    Soligenix is in Pharmaceuticals
  4. Who are Soligenix's competitors?

    Soligenix's top competitors are Celtaxsys, Alder BioPharmaceuticals, VBI Vaccines